Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Holdings
Fierce Biotech
Novo Holdings-backed biotech raises $205M to fill gout care gap
Crystalys and its team of 10 people—and growing—is pushing ahead in hopes of filling the treatment gap for patients with gout.
Gabrielle Masson
Sep 30, 2025 8:00am
Paratek buys Optinose, rhinosinusitis spray Xhance for up to $330M
Mar 20, 2025 11:23am
Novo Nordisk figures sales growth will slow slightly in 2025
Feb 5, 2025 11:43am
2024's top biopharma M&A deals
Jan 13, 2025 3:00am
Novo Holdings' $16.5B Calalent buyout to close in 'coming days'
Dec 16, 2024 11:51am
European officials approve Novo Holdings' planned Catalent buy
Dec 6, 2024 2:48pm
